How Wazoku Crowd has Solved Challenges in Neurology

Driving Innovation in Neurology with Wazoku’s Open Innovation Platform

Neurological diseases present some of the most complex challenges in healthcare, from accurately measuring cognitive decline to developing reliable animal models for psychiatric research. At Wazoku, we empower organizations to solve these critical problems by tapping into a global network of innovators through our Open Innovation Platform. By fostering collaboration across disciplines, we’ve helped organizations find groundbreaking solutions for neurological conditions such as multiple sclerosis (MS), schizophrenia, and central nervous system (CNS) development in children.

On this page, you’ll explore how Wazoku Crowd has tackled neurology’s toughest challenges, offering practical solutions that advance research and improve patient outcomes. From cognitive assessment tools for MS patients to cutting-edge animal models for psychiatric diseases, Wazoku’s open innovation platform enables transformative breakthroughs in the field of neurology.

Neurology Innovation Challenge: Measuring Central Nervous System Development in Infants and Children

Assessing central nervous system (CNS) development in infants is a complex task, as current methods have significant limitations. Existing tests, whether biological or behavioral, struggle to provide reliable, non-invasive data, especially in multicenter studies. The need for standardized, minimally invasive, and effective markers is critical for tracking CNS development in children from birth to two years old.

This challenge, solved through Wazoku’s Open Innovation platform, sought innovative proposals for behavioral or biological markers that could be easily administered in a pediatrician’s clinic. The solutions needed to assess CNS development through metrics linked to psychological constructs such as working memory, attention, and emotion regulation while differentiating individual differences and detecting clinically relevant deficits.

How the Wazoku Crowd Delivered: Through global collaboration, the Wazoku Crowd provided novel approaches in:

• Psychological Measurements: Age-appropriate techniques that can be administered during routine pediatric visits, offering quick and reliable insights.
• Biological Measurements: Non-invasive methods using samples like saliva or peripheral blood that could be easily integrated into well-baby visits without causing distress to the child or parents.

These proposals offered scalable solutions that met the Seeker’s need for standardization and practical application in clinical settings, transforming how CNS development can be measured in early childhood.

Explore More: Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Reliable Assessment of Cognitive Function in Multiple Sclerosis (MS) Patients

Multiple sclerosis (MS) is a progressive disease that not only affects motor functions but also leads to cognitive decline. Although the Brief International Cognitive Assessment for MS (BICAMS) is the standard screening tool, it is rarely used in clinical practice due to its complexity and the need for trained personnel. To address this gap, the Seeker, through Wazoku’s Open Innovation platform, sought new approaches to assess cognitive function that could be self-administered, allowing MS patients to track their cognitive health from home over time.

The solution needed to:

• Be simple, user-friendly, and consistently reliable.
• Measure cognitive functions like attention, memory, problem-solving, and more.
• Be suitable for use without the need for a healthcare professional, or with minimal help from a caregiver or family member.

How the Wazoku Crowd Solved It: The Wazoku Crowd responded with innovative solutions that:

• Created cognitive tests that were self-administered, easy to use, and required no professional supervision.
• Ensured tests provided accurate, trackable data for long-term monitoring, with an option to share results with clinicians.
• Integrated mood and symptom tracking, allowing patients to monitor their cognitive health in conjunction with their overall well-being.

These solutions provided a practical, scalable approach for MS patients to monitor their cognitive performance regularly, transforming cognitive assessment into a manageable, at-home process.

Explore More: Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Wazoku Open Innovation

Wazoku’s Open Innovation platform has proven to be a powerful tool for solving complex challenges. By bringing together a global community of solvers, Wazoku helps leading organizations in the Health and Life Sciences industry tackle their toughest problems, drive innovation, and improve patient outcomes.

Whether through cutting-edge technologies like AI, precision medicine, or patient-centered research, Wazoku Crowd continues to push the boundaries of what’s possible in healthcare innovation.

Ready to innovate?

Run your own challenge and leverage global collaboration to find solutions to your organization’s most pressing neurological challenges.

Explore